In prostate cancer, however, it has been shown that NDRG1 overexpression maintains membrane E-cadherin and β-catenin and inhibits TGF-β-induced EMT, thus inhibiting cell migration and invasion (30). The gene discussed is NDRG1; the disease is prostate carcinoma.